Quarterly report pursuant to Section 13 or 15(d)

Licenses Acquired - Summary Of Research and Development Arrangement Contract (Detail)

v3.3.0.814
Licenses Acquired - Summary Of Research and Development Arrangement Contract (Detail) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2015
Sep. 30, 2014
Sep. 30, 2015
Sep. 30, 2014
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total $ 1,895 $ 0 $ 10,882 $ 0
IV Tramadol [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total [1] 0   3,000  
Mustang Therapeutics, Inc [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total 0   2,147  
Checkpoint Therapeutics, Inc [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total 600   2,633  
Coronado SO Co, Inc [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total 0   1,607  
Helocyte [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total 0   200  
Escala [Member]        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Research and Development Total $ 1,295   $ 1,295  
[1] Fortress intends to transfer IV Tramadol to Avenue